Changes in proteasome structure and function caused by HAMLET in tumor cells

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Gustafsson, Lotta ^a   Aits, Sonja ^a   Önnerfjord, Patrik ^b   Trulsson, Maria ^a   Storm, Petter ^a   Svanborg, Catharina ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA LACTALBUMIN; HAMLET PROTEIN; HUMAN ALPHA LACTALBUMIN MADE LETHAL TO TUMOR CELLS PROTEIN; PROTEASOME; PROTEOLIPID PROTEIN; UNCLASSIFIED DRUG; BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; CYSTEINE PROTEINASE INHIBITOR; HAMLET COMPLEX, HUMAN; LACTALBUMIN; LEUPEPTIN; OLEIC ACID; PROTEIN SUBUNIT;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVE SITE; ENZYME INHIBITION; FRAGMENTATION REACTION; HOST CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; INTERNALIZATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN LIPID INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; TUMOR CELL; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN CONFORMATION; PROTEIN MICROARRAY; TUMOR CELL LINE;

CELL DEATH; CELL LINE, TUMOR; CYSTEINE PROTEINASE INHIBITORS; HUMANS; LACTALBUMIN; LEUPEPTINS; MODELS, MOLECULAR; OLEIC ACID; OLEIC ACIDS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN ARRAY ANALYSIS; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN SUBUNITS;

EID: 65349095292     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005229     Document Type: Article

References (40)

1. Goldberg AL (1995) Functions of the proteasome: the lysis at the end of the tunnel. Science 268: 522-523.
2. Coux O, Tanaka K, Goldberg AL (1996) Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65: 801-847.
3. Goldberg AL (2003) Protein degradation and protection against misfolded or damaged proteins. Nature 426: 895-899.
4. Ciechanover A (2006) Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Exp Biol Med (Maywood) 231: 1197-1211.
5. LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8: 499-509.
6. Gregori L, Fuchs C, Figueiredo-Pereira ME, Van Nostrand WE, Goldgaber D (1995) Amyloid beta-protein inhibits ubiquitin-dependent protein degradation in vitro. J Biol Chem 270: 19702-19708.
7. Kristiansen M, Deriziotis P, Dimcheff DE, Jackson GS, Ovaa H, et al. (2007) Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell 26: 175-188.
8. Hakansson A, Zhivotovsky B, Orrenius S, Sabharwal H, Svanborg C (1995) Apoptosis induced by a human milk protein. Proc Natl Acad Sci U S A 92: 8064-8068.
9. Svensson M, Hakansson A, Mossberg AK, Linse S, Svanborg C (2000) Conversion of alpha-lactalbumin to a protein inducing apoptosis. Proc Natl Acad Sci U S A 97: 4221-4226.
10. Mossberg AK, Wullt B, Gustafsson L, Mansson W, Ljunggren E, et al. (2007) Bladder cancers respond to intravesical instillation of HAMLET (human alpha-lactalbumin made lethal to tumor cells). Int J Cancer 121: 1352-1359.
11. Fischer W, Gustafsson L, Mossberg AK, Gronli J, Mork S, et al. (2004) Human alpha-lactalbumin made lethal to tumor cells (HAMLET) kills human glioblastoma cells in brain xenografts by an apoptosis-like mechanism and prolongs survival. Cancer Res 64: 2105-2112.
12. Gustafsson L, Leijonhufvud I, Aronsson A, Mossberg AK, Svanborg C (2004) Treatment of skin papillomas with topical alpha-lactalbumin-oleic acid. N Engl J Med 350: 2663-2672.
13. Ebner KE, Denton WL, Brodbeck U (1966) The substitution of alpha-lactalbumin for the B protein of lactose synthetase. Biochem Biophys Res Commun 24: 232-236.
14. Brodbeck U, Ebner KE (1966) Resolution of a soluble lactose synthetase into two protein components and solubilization of microsomal lactose synthetase. J Biol Chem 241: 762-764.
15. Brew K, Vanaman TC, Hill RL (1968) The role of alpha-lactalbumin and the A protein in lactose synthetase: a unique mechanism for the control of a biological reaction. Proc Natl Acad Sci U S A 59: 491-497.
16. Svensson M, Fast J, Mossberg AK, Duringer C, Gustafsson L, et al. (2003) Alpha-lactalbumin unfolding is not sufficient to cause apoptosis, but is required for the conversion to HAMLET (human alpha-lactalbumin made lethal to tumor cells). Protein Sci 12: 2794-2804.
17. Kuwajima K (1996) The molten globule state of alpha-lactalbumin. FASEB J 10: 102-109.
18. Wu LC, Schulman BA, Peng ZY, Kim PS (1996) Disulfide determinants of calcium-induced packing in alpha-lactalbumin. Biochemistry 35: 859-863.
19. Dobson CM (1999) Protein misfolding, evolution and disease. Trends Biochem Sci 24: 329-332.
20. Wenzel T, Baumeister W (1995) Conformational constraints in protein degradation by the 20S proteasome. Nat Struct Biol 2: 199-204.
21. Gustafsson L (2005) HAMLET - In vivo effects and mechanisms of tumor-cell death [Doctoral Thesis]. Lund: Lund University.
22. Rao KR, Brew K (1989) Calcium regulates folding and disulfide-bond formation in alpha-lactalbumin. Biochem Biophys Res Commun 163: 1390-1396.
23. Ewbank JJ, Creighton TE (1993) Pathway of disulfide-coupled unfolding and refolding of bovine alpha-lactalbumin. Biochemistry 32: 3677-3693.
24. Chandra N, Brew K, Acharya KR (1998) Structural evidence for the presence of a secondary calcium binding site in human alpha-lactalbumin. Biochemistry 37: 4767-4772.
25. Smith LJ, Dobson CM, van Gunsteren WF (1999) Molecular dynamics simulations of human alpha-lactalbumin: changes to the structural and dynamical properties of the protein at low pH. Proteins 36: 77-86.
26. Stefani M, Dobson CM (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med 81: 678-699.
27. Dobson CM (2004) Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol 15: 3-16.
28. Kaufman RJ (2002) Orchestrating the unfolded protein response in health and disease. J Clin Invest 110: 1389-1398.
29. Safar J, Roller PP, Gajdusek DC, Gibbs CJ Jr (1994) Scrapie amyloid (prion) protein has the conformational characteristics of an aggregated molten globule folding intermediate. Biochemistry 33: 8375-8383.
30. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136-144.
31. Whitby FG, Masters EI, Kramer L, Knowlton JR, Yao Y, et al. (2000) Structural basis for the activation of 20S proteasomes by 11S regulators. Nature 408: 115-120.
32. Hill CP, Masters EI, Whitby FG (2002) The 11S regulators of 20S proteasome activity. Curr Top Microbiol Immunol 268: 73-89.
33. Groll M, Bajorek M, Kohler A, Moroder L, Rubin DM, et al. (2000) A gated channel into the proteasome core particle. Nat Struct Biol 7: 1062-1067.
34. Watanabe N, Yamada S (1996) Activation of 20S proteasomes from spinach leaves by fatty acids. Plant Cell Physiol 37: 147-151.
35. Hedlund M, Svensson M, Nilsson A, Duan RD, Svanborg C (1996) Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli. J Exp Med 183: 1037-1044.
36. Karpman D, Hakansson A, Perez MT, Isaksson C, Carlemalm E, et al. (1998) Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies. Infect Immun 66: 636-644.
37. Svensson M, Sabharwal H, Hakansson A, Mossberg AK, Lipniunas P, et al. (1999) Molecular characterization of alpha-lactalbumin folding variants that induce apoptosis in tumor cells. J Biol Chem 274: 6388-6396.
38. Satoh J, Nanri Y, Yamamura T (2006) Rapid identification of 14-3-3-binding proteins by protein microarray analysis. J Neurosci Methods 152: 278-288.
39. Acharya KR, Ren JS, Stuart DI, Phillips DC, Fenna RE (1991) Crystal structure of human alpha-lactalbumin at 1.7 A resolution. J Mol Biol 221: 571-581.
40. Koradi R, Billeter M, Wuthrich K (1996) MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph 14: 51-55, 29-32.